Travere Therapeutics ( (TVTX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Travere Therapeutics’ stock movement has been influenced by mixed analyst ratings. Despite reporting a quarterly net loss, Guggenheim reiterated a Buy rating, citing positive long-term prospects. Evercore ISI lowered its price target due to revised revenue expectations but maintained a Buy rating, showing confidence in the company’s strategic direction. Meanwhile, Stifel raised its price target following improvements in financial performance, highlighting optimism about Travere’s growth potential.
More about Travere Therapeutics
YTD Price Performance: 29.89%
Average Trading Volume: 1,970,696
Technical Sentiment Signal: Buy
Current Market Cap: $2.2B
For further insights into TVTX stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.